Gabelli Funds LLC reduced its stake in McKesson Co. (NYSE:MCK – Free Report) by 18.4% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,500 shares of the company’s stock after selling 3,500 shares during the period. Gabelli Funds LLC’s holdings in McKesson were worth $9,053,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also modified their holdings of the stock. LRI Investments LLC acquired a new stake in McKesson in the 1st quarter valued at $28,000. Register Financial Advisors LLC acquired a new stake in shares of McKesson in the 1st quarter valued at $29,000. Richardson Financial Services Inc. bought a new stake in shares of McKesson in the 4th quarter worth about $31,000. Carolinas Wealth Consulting LLC grew its holdings in shares of McKesson by 42.9% in the 4th quarter. Carolinas Wealth Consulting LLC now owns 80 shares of the company’s stock worth $37,000 after purchasing an additional 24 shares during the last quarter. Finally, ICA Group Wealth Management LLC acquired a new stake in shares of McKesson during the 4th quarter worth about $40,000. 85.07% of the stock is owned by institutional investors and hedge funds.
Insider Transactions at McKesson
In related news, CEO Brian S. Tyler sold 3,753 shares of the business’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $626.03, for a total transaction of $2,349,490.59. Following the completion of the transaction, the chief executive officer now owns 82,339 shares in the company, valued at $51,546,684.17. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In the last ninety days, insiders sold 11,259 shares of company stock worth $6,635,492. 0.11% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Read Our Latest Report on McKesson
McKesson Trading Down 0.6 %
Shares of NYSE:MCK opened at $505.00 on Tuesday. McKesson Co. has a 1-year low of $431.35 and a 1-year high of $637.51. The stock has a market capitalization of $65.62 billion, a P/E ratio of 22.56, a P/E/G ratio of 1.18 and a beta of 0.44. The business has a 50-day moving average price of $558.79 and a two-hundred day moving average price of $557.07.
McKesson (NYSE:MCK – Get Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The company reported $7.88 earnings per share for the quarter, topping analysts’ consensus estimates of $7.21 by $0.67. McKesson had a net margin of 0.94% and a negative return on equity of 242.57%. The business had revenue of $79.28 billion during the quarter, compared to the consensus estimate of $82.53 billion. During the same period in the previous year, the firm posted $7.27 earnings per share. McKesson’s revenue for the quarter was up 6.4% compared to the same quarter last year. As a group, equities analysts predict that McKesson Co. will post 32.11 EPS for the current year.
McKesson Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 1st. Shareholders of record on Monday, September 2nd will be issued a dividend of $0.71 per share. The ex-dividend date of this dividend is Friday, August 30th. This represents a $2.84 dividend on an annualized basis and a yield of 0.56%. This is a boost from McKesson’s previous quarterly dividend of $0.62. McKesson’s dividend payout ratio (DPR) is 12.69%.
McKesson Company Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Read More
- Five stocks we like better than McKesson
- How to buy stock: A step-by-step guide for beginners
- The Average 401k Balance by Age Explained
- What is the Nikkei 225 index?
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- What is a buyback in stocks? A comprehensive guide for investors
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.